SEGMENTED INFORMATION (Details) - USD ($)	3 Months Ended				6 Months Ended
	Jun. 30, 2022	Mar. 31, 2022	Jun. 30, 2021	Mar. 31, 2021	Jun. 30, 2022	Jun. 30, 2021
REVENUE	$ 2,485,101		$ 3,092,171		$ 5,514,046	$ 6,541,330
COST OF REVENUE	(2,241,779)		(2,624,564)		(4,937,185)	(5,491,158)
GROSS (LOSS)/PROFIT	243,322		467,607		576,861	1,050,172
OTHER INCOME	52,836		50,429		99,230	112,916
FINANCE COSTS	(2,319)		(3,448)		(5,645)	(6,837)
Tax expense	1,621		(108,280)		(12,678)	(108,280)
NET PROFIT/(LOSS)	$ (138,662)	$ 17,066	$ 28,262	$ 338,744
TOTAL [Member]
REVENUE					5,514,046	6,541,330
COST OF REVENUE					(4,937,185)	(5,491,158)
GROSS (LOSS)/PROFIT					576,861	1,050,172
OTHER INCOME					99,230	112,916
General and administrative					(779,364)	(680,265)
FINANCE COSTS					(5,645)	(6,837)
PROFIT/(LOSS) BEFORE TAX					(108,918)	475,286
Tax expense					(12,678)	(108,280)
NET PROFIT/(LOSS)					(121,596)	367,006
BioNexus Malaysia [Member]
REVENUE					33,467	465,470
COST OF REVENUE					(58,372)	(358,528)
GROSS (LOSS)/PROFIT					(24,905)	106,942
OTHER INCOME					4,285	3,848
General and administrative					(51,238)	(44,128)
FINANCE COSTS					(1,860)	(2,303)
PROFIT/(LOSS) BEFORE TAX					73,718	64,359
Tax expense					0	(654)
NET PROFIT/(LOSS)					(73,718)	63,705
Chemrex [Member]
REVENUE					5,480,579	6,075,860
COST OF REVENUE					(4,878,813)	(5,132,630)
GROSS (LOSS)/PROFIT					601,766	943,230
OTHER INCOME					94,945	109,068
General and administrative					(618,348)	(556,619)
FINANCE COSTS					(3,785)	(4,534)
PROFIT/(LOSS) BEFORE TAX					74,578	491,145
Tax expense					(12,678)	107,626
NET PROFIT/(LOSS)					61,900	383,519
BGLC [Member]
REVENUE					0	0
COST OF REVENUE					0	0
GROSS (LOSS)/PROFIT					0	0
OTHER INCOME					0	0
General and administrative					(109,778)	(80,218)
FINANCE COSTS					0	0
PROFIT/(LOSS) BEFORE TAX					(109,778)	(80,218)
Tax expense					0	0
NET PROFIT/(LOSS)					$ (109,778)	$ (80,218)